Edwards Martin is a director of Verona Pharma Plc.
Person profile
Roles
Verona Pharma
Director
Morphic Holding
Director
Reata Pharmaceuticals
Director
Inozyme Pharma
Director
Address
Burlington, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Verona Pharma plc
22 Nov 23
4
Morphic Holding, Inc.
15 Nov 23
4
REATA PHARMACEUTICALS INC
26 Sep 23
4
Inozyme Pharma, Inc.
15 Jun 23
4
REATA PHARMACEUTICALS INC
9 Jun 23
4
Morphic Holding, Inc.
5 Jun 23
4
Verona Pharma plc
28 Apr 23
4
Inozyme Pharma, Inc.
14 Jun 22
4
Morphic Holding, Inc.
10 Jun 22
4
REATA PHARMACEUTICALS INC
9 Jun 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
20 Nov 23 | VRNA Verona Pharma | Ordinary Shares | Buy | Acquire P | No | No | 1.837 | 33,736 | 61.97 k | 144,800 |
13 Nov 23 | MORF Morphic Holding | Common Stock | Buy | Acquire P | No | No | 20.54 | 2,376 | 48.80 k | 2,376 |
26 Sep 23 | RETA Reata Pharmaceuticals | Class A common stock | Sale back to company | Dispose D | No | No | 0 | 6,116 | 0.00 | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Stock Option Class A common stock | Sale back to company | Dispose D | No | No | 93.61 | 2,137 | 200.04 k | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Stock Option Class A common stock | Sale back to company | Dispose D | No | No | 93.61 | 169 | 15.82 k | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Stock Option Class A common stock | Sale back to company | Dispose D | No | No | 34.76 | 5,620 | 195.35 k | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Stock Option Class A common stock | Sale back to company | Dispose D | No | No | 34.76 | 520 | 18.08 k | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Stock Option Class A common stock | Sale back to company | Dispose D | No | No | 27.32 | 99 | 2.70 k | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Stock Option Class A common stock | Sale back to company | Dispose D | No | No | 146.01 | 5,000 | 730.05 k | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Stock Option Class A common stock | Sale back to company | Dispose D | No | No | 149.29 | 6,300 | 940.53 k | 0 |